Abhay Joshi, Ph.D., MBA

The National Academy of Engineering (NAE) elected 128 new members and 22 international members to the Class of 2025, announced NAE President John L. Anderson today. This brings the total U.S. membership to 2,487 and the number of international members to 336.

Election to the National Academy of Engineering is among the highest professional distinctions accorded to an engineer. Academy membership honors those who have made outstanding contributions in at least one of the following categories: “engineering practice, research, or education”, “pioneering of new and developing fields of technology, major advancements in traditional fields of engineering, or development/implementation of innovative approaches to engineering education” or “engineering leadership of one or more major endeavors.” NAE members are among the world’s most accomplished engineers from business, academia, and government. Founded in 1964, the NAE provides independent, objective analysis and advice to the nation, offering leadership and insights for a complex world. Elected by their peers, the ballot for this class was set in December and the final vote took place in January.

Individuals in the newly elected class will be formally inducted during the NAE’s Annual Meeting on Oct. 5, 2025. A list of the new members and international members follows, with their primary affiliations at the time of election and a brief statement of their principal engineering accomplishments.

…

Joshi, Abhay, president and chief executive officer, Axent Biosciences, San Mateo, Calif. For taking botulinum toxin medicines from initial lab-scale production to global commercialization and distribution… Continue reading.

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Abhay Joshi, Ph.D., MBA, Chief Operating Officer, , Revance Therapeutics, to its College of Fellows. Dr. Joshi was nominated, reviewed, and elected by peers and members of the College of Fellows For taking BOTOX from initial lab-scale production, formulation, GMP manufacturing, scale-up, and supply chain logistics to global commercialization and distribution.